MKNK2 and prostate carcinoma: It should be noted that another recent study employed a mass spectrometric approach and found that rapamycin alters phosphorylation of Mnk2 on Ser-437 in prostate cancer cells, triggering Mnk2 activation and eIF4E phosphorylation independently of MAPKs [35].